Four years ago, my colleague and management team member here at BBK Worldwide, Rob Laurens, wrote the blog post, “How a Poster Enrolled my Clinical Trial.” I re-read it recently and thought it would be fun to look back on this article to see how our ideas about patient engagement and enrollment may have changed over the last few years thanks to technology and the rise of mHealth.
It’s official – more GoogleTM searches now take place on mobile devices than on personal computers. As clinical trial marketers, it’s time to embrace mobile as the primary screen for engaging patients. So what makes search on a mobile device so different? It turns out, quite a bit.
Topics: Mobile Strategies
We’re incredibly proud to have our My Protocol Pal (SM) mobile app and site engagement platform featured in PharmaVOICE’s inaugural Innovation issue, out today. Designed to recognize organizations that are breaking new ground, the issue celebrates “the culture of innovation and achievement across the global healthcare/pharmaceutical industry spectrum.
Members of the BBK Worldwide team periodically attend industry events throughout the year. We love to network and learn from our peers, and when we are invited to speak we jump at the opportunity to bring our own expertise to the table and join in the conversation.
Early last week Apple excited many and rattled others with its ResearchKit announcement. The open-source toolkit or “framework” includes disease-specific applications that patients can use to track their symptoms, and will allow researchers to gather data from iPhone users to help further medical research. While reaction has been mixed, most agree that tools that help medical science advance and make people and patients more involved are welcome innovations. But clinical research and medical research aren’t the same. Running a global clinical trial is much different than creating and delivering apps to aid research on a particular disease.
Reimbursing patients should be easy. Yet, often enough, it is one of the most challenging programs for sponsors to implement. When comparing reimbursement options, make sure your program isn't lacking these five essentials.
Pediatric studies are often difficult to enroll. And once the first-patient-in date has passed and the enrollment clock starts ticking, your difficult-to-enroll study can quickly become in peril of missing its planned last-patient-in date. BBK Worldwide has extensive experience bolstering enrollment efforts even after first-patient-in. Today, we're sharing a few pediatric case studies that achieved enrollment despite a slow start.
Streaming radio adoption has been astronomical around the world. People tune in every day on their phones, tablets, and desktops (BBK even has its very own Spotify playlist!). This gives you the perfect opportunity to get your clinical study in front of the right people – straight to their earbuds! Oh... did we forget to mention how cost-effective it is?
Clinical studies today rely heavily on the transparency of real-time enrollment data that can be disseminated, analyzed, and evaluated to make critical decisions at a moment in time. But what is the best way to be looking at and analyzing these metrics? Where can this data be tracked in one, single location to provide real-time enrollment metrics and reporting? BBK Worldwide’s patented patient recruitment Web portal, TrialCentralNet (TCN®), houses all of these features and more. Hundreds of users log in to this secure portal every day to access their study metrics related to clinical trial enrollment projections and site performance. But how does it work? What does TCN possess that makes it so unique and dynamic? Here are a few features of the system that make TCN stand out in the clinical trial data crowd:
Towards the end of the third age of our earth, great Internet browsers of power were forged by the tech smiths of Silicon Valley.